Rhodamine-RCA in vivo labeling guided laser capture microdissection of cancer functional angiogenic vessels in a murine squamous cell carcinoma mouse model

Molecular Cancer

Volumn 5, Issue , 2006, Pages

  Hunter, Finie ^a   Xie, Jianwu ^a   Trimble, Cameron ^a   Bur, Monica ^a   Li, King C P ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CD31 ANTIGEN; KERATIN; PHYTOHEMAGGLUTININ; RHODAMINE; RICINUS COMMUNIS EXTRACT; RNA; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTROPHORESIS; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE MICROSCOPY; FROZEN SECTION; GENE LOCATION; GENOME ANALYSIS; IN VIVO STUDY; LABELING INDEX; LASER CAPTURE MICRODISSECTION; MOUSE; NONHUMAN; PATHOLOGICAL ANATOMY; PRACTICE GUIDELINE; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; TISSUE DISTRIBUTION; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANIMALS; BASE SEQUENCE; BLOOD VESSELS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SEPARATION; ENDOTHELIAL CELLS; FEMALE; FLUORESCENT DYES; LASERS; MICE; MICE, INBRED C3H; MICRODISSECTION; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PLANT LECTINS; RHODAMINES; STAINING AND LABELING;

ANIMALIA; MURINAE; RICINUS COMMUNIS;

EID: 33646153765     PISSN: 14764598     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-5-5     Document Type: Article

References (35)

1. Fend F, Specht K, Kremer M, Quintanilla-Martinez L: Laser capture microdissection in pathology. Methods Enzymol 2002, 356:196-206.
2. Cantz T, Jochheim A, Cieslak A, Hillemann T, Scharf J, Manns MP, Ott M: PCR based quantification of amplified RNA from laser microdissected mouse liver samples. Experimental and Molecular Pathology 2003, 75:53-57.
3. BC Decker Inc: Novel Technologies for Identification of Metastasis and Invasion-Promoting Genes and Gene Products:. Cancer Medicine 5th edition. 2000.
4. Wulfkuhle JD, McLean KC, Paweletz CP, Sgroi DC, Trock BJ, Steeg PS, Petricoin EF 3rd: New approaches to proteomic analysis of breast cancer. Proteomics 2001, 1:1205-1215.
5. Jones MB, Krutzsch H, Shu H, Zhao Y, Liotta LA, Kohn EC, Petricoin EF 3rd: Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomic 2002, 2:76-84.
6. Ornstein DK, Gillespie JW, Paweletz CP, Duray PH, Herring J, Vocke CD, Topalian SL, Bostwick DG, Linehan WM, Petricoin EF 3rd, Emmert-Buck MR: Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 2000, 21:2235-2242.
7. Leethanakul C, Patel V, Gillespie J, Shillitoe E, Kellman RM, Ensley JF, Limwongse V, Emmert-Buck MR, Krizman DB, Gutkind JS: Gene expression profiles in squamous cell carcinomas of the oral cavity: use of laser capture microdissection for the construction and analysis of stage-specific cDNA libraries. Oral Onco 2000, 36:474-83.
8. Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S, Liotta LA, Emmert-Buck M, Gutkind JS: Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 2000, 19:3220-3224.
9. Sugiyama Y, Sugiyama K, Hirai Y, Akiyama F, Hasumi K: Microdissection is essential for gene expression profiling of clinically resected cancer tissues. Am J Clin Pathol 2002, 117:109-116.
10. Hood JD, Bednarski M, Frausto R, Guccione S, Reisfeld RA, Xiang R, Cherish DA: Tumor Regression by Targeted Gene Delivery to the Neovasculature. Science 2002, 296:2404-2407.
11. Siemann DW, Horsman MR: Targeting the tumor vasculature: a strategy to improve radiation therapy. Expert Rev Anticancer Ther 2004, 4:321-327.
12. Ruoslahti E: Specialization of Tumour Vasculature. Nature Reviews Cancer 2002, 2:83-90.
13. Wary KK: Molecular Targets for anti-angiogenic therapy. Curr Opin Mol Ther 2004, 6:54-70.
14. Thorpe PE: Vascular targeting agents as cancer therapeutics. Clinical Cancer Research 2004, 10:415-427.
15. Segal MS, Bihorac A, Koc M: Circulating endothelial cell: tea leaves for renal disease. Am J Ren Physiology 2002, 283:F11-F19.
16. Gottesman M: Cancer Gene therapy: an awkward adolescence. Cancer Gene Therapy 2003, 10:501-508.
17. Carter P, Smith L, Ryan M: Identification and validation of cell surface antigens for antibody targeting in oncology. Endocrine-Related Cancer 2004, 11:659-687.
18. Morabito A, Sarmiento R, Bonginelli P, Gasparini G: Antiangiogenic strategies, compounds, and early clinical results in breast cancer. Critical Reviews in Oncology/Hematology 2004, 49:91-107.
19. Miettinen M, Lindenmayer AE, Chaubal A: Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Modern Pathology 1994, 1:82-90.
20. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM: Ultrastructural localization of platelet endothelial cell adhesion molecule (PECAM-1, CD31) in vascular endothelium. J Histochem Cytochem 2004, 52:87-101.
21. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM: Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002, 109:337-346.
22. Fukumoto M: Histochemical study using lectin and anti-human von Willebrand factor antibody of oral hemangioma. Nichidai Koko Kagaku 1989, 15(4):431-40.
23. Mojsilovic-Petrovic J, Nesic M, Pen A, Zhang W, Stanimirovic D: Development of rapid staining protocols for laser capture microdissection of brain vessels from human and rat coupled to gene expression analysis. Journal of Neuroscience Methods 2004, 133:39-48.
24. Fend F, Emmert-Buck MR, Chuaqui R, Cole K, Lee J, Liotta LA, Raffeld M: Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. American Journal of Pathology 1999, 154:61-66.
25. Mikulowska-Meenis A, Taylor TB, Vishnu P, Michie SA, Raja R, Horner N, Kunitake ST: High-quality RNA from cells isolated by laser capture microdissection. Biotechniques 2002, 33:176-179.
26. Murakami H, Liotta L, Star RA: IF-LCM: Laser capture microdissection of immunofluorescently defined cells for mRNA analysis. Kidney International 2000, 58:1346-1353.
27. Gerhart DZ, Zlonis MS, Drewes LR: Light and electron microscopic localization of D-galactosyl residues in capillary endothelial cells of the canine cerebral cortex. The Histochemistry Society 1986, 34(5):641-648.
28. Freitas RA: Nanomedicine. In Basic Capabilities, Landes Bioscience Volume I. Georgetown, TX; 1999.
29. Chang YS, di Tomaso, E, McDonald DM, Jones R, Jain RK, Munn L: Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood. Medical Sciences 2000, 97:14608-14613.
30. Kohda Y, Murakami H, Moe OW, Star RA: Analysis of segmental renal gene expression by laser capture microdissection. Kidney Int 2000, 57(1):321-31.
31. Zhang W, Mojsilovic-Petrovic J, Andrade MF, Zhang H, Ball M, Stanimirovic DB: Expression and functional characterization of ABCG2 in brain endothelial cells and vessels. The FASEB Journal 2003. 10.1096/ fj.02-1131fje
32. Crowe DL, Milo GE, Shuler CF: Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential. J Dent Res 1999, 78:1256-1263.
33. Lussier M, Filion M, Compton JG, Nadeau JH, Lapointe L, Royal A: The mouse keratin 19 encoding gene; sequence, structure and chromosomal assignment. Gene 1990, 95:203-213.
34. Culp LA, Lin WC, Kleinman NR, Campero NM, Miller CJ, Holleran JL: Tumor progression, micrometastasis, and genetic instability tracked with histochemical marker genes. Prog Histochem Cytochem 1998, 33:329-348.
35. Ribatti D, Nico B, Vacca A, Roncali L, Dammacco F: Endothelial Cell Heterogeneity and Organ Specificity. J Hematother Stem Cell Res 2002, 11(1):81-90.